Annual report [Section 13 and 15(d), not S-K Item 405]

DISCONTINUED OPERATIONS

v3.26.1
DISCONTINUED OPERATIONS
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS

NOTE 18 - DISCONTINUED OPERATIONS


As discussed in Note 2 above, on October 15, 2025, the Company entered into the Venom APA with Venom, to divest the Volcon brand in exchange for a non-dilutable 10% equity position in Venom’s reorganized Delaware corporation on a fully-diluted basis, which reorganization has not occurred as of March 25, 2026 and will be recognized by the Company once completed. The Company transferred all Volcon IP, including all intellectual property, brand assets, trademarks, sales and distribution networks and engineering documentation associated with the Volcon brand (the “IP”) other than its E-Bike, the Brat. The Company will have the right to appoint one director to Venom’s board and may continue to finance Venom’s inventory purchases. In the event that Venom does not complete its corporate reorganization within six months, the Company will have the option to repurchase the Volcon IP for a nominal amount.

 

The Company concluded that it would shift its business operations in the fourth quarter after the implementation of the digital asset treasury strategy. The Company expects that by selling the four-wheel product business, which includes the HF1 UTV, MN1 Tradesman UTV and MN1 Adventurer products (collectively the “Divested Products”), it will reduce the Company’s future product liability exposure. Although the Company may continue to finance Venom’s inventory purchases and obtain a seat on Venom’s board of directors, the Company has concluded that it does not have significant ongoing involvement in the products sold in the Venom APA. The revenue and expenses associated with the Divested Products are presented as discontinued operations. Expenses also include certain allocated costs such as salaries, benefits, travel, marketing and consulting costs which are allocated based on actual costs or estimated time that individuals worked on these products.

 

Following this divestiture, the Company will concentrate on its two-wheel business, including the launch of new products in the U.S. and Europe. The Company also plans to expand its inventory financing operations to generate positive cash flow by leveraging the spread between the Company’s cost of capital and interest income. Revenues and expenses for the two-wheel business and inventory financing business will be presented in the loss from continuing operations. Although the Company transferred the tradenames, design patents and engineering drawings for the Grunt, Grunt EVO and Stag in the Venom APA, the Company had discontinued the sale of these products before the shift in operations therefore revenues and costs associated with these products are also presented in the loss from continuing operations.

 

The following table presents the carrying amount of the major classes of assets and liabilities included in the consolidated balance sheet that are related to discontinued operations:

               
    2025     2024  
             
ASSETS                
                 
Accounts receivable   $ 256,459     $ 19,642  
Inventory     11,654       700,450  
Inventory deposits           147,975  
Prepaid expenses and other current assets           717  
Intangible asset           15,698  
Total assets   $ 268,113     $ 884,482  
                 
LIABILITIES                
                 
Accounts payable   $ 76,290     $ 19,236  
Accrued liabilities     16,732       32,618  
Customer deposits           122,046  
Total liabilities   $ 93,022     $ 173,900  

 

The following table presents the major classes of line items representing the loss on discontinued operations:

               
    2025     2024  
             
Revenue   $ 919,797     $ 53,725  
Cost of goods sold     (927,910 )     (180,337 )
Sales and marketing     (890,493 )     (320,926 )
Product development     (504,645 )     (810,939 )
General and administrative expenses     (78,393 )     (97,773 )
Loss from discontinued operations   $ (1,481,644 )   $ (1,356,250 )

 

The impact to the statement of cash flows for discontinued operations was not material for any period presented.